Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: Case-control study Academic Article uri icon

Overview

MeSH Major

  • Prostate-Specific Antigen
  • Prostatic Neoplasms

abstract

  • The concentration of prostate specific antigen at age 60 predicts lifetime risk of metastasis and death from prostate cancer. Though men aged 60 with concentrations below the median (≤1 ng/ml) might harbour prostate cancer, it is unlikely to become life threatening. Such men could be exempted from further screening, which should instead focus on men with higher concentrations.

publication date

  • September 18, 2010

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC2939950

Digital Object Identifier (DOI)

  • 10.1136/bmj.c4521

PubMed ID

  • 20843935

Additional Document Info

start page

  • c4521

volume

  • 341

number

  • 7773